HomeIVBXF • OTCMKTS
add
Innovent Biologics Inc
Previous close
$5.38
Day range
$5.42 - $5.42
Year range
$3.55 - $6.41
Market cap
66.53B HKD
Avg Volume
1.66K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.75B | 51.27% |
Operating expense | 1.72B | 3.70% |
Net income | -444.38M | 27.67% |
Net profit margin | -25.36 | 52.19% |
Earnings per share | — | — |
EBITDA | -428.56M | 44.13% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.97B | 19.68% |
Total assets | 20.63B | 17.28% |
Total liabilities | 8.10B | 18.09% |
Total equity | 12.53B | — |
Shares outstanding | 1.62B | — |
Price to book | 0.70 | — |
Return on assets | -5.82% | — |
Return on capital | -7.43% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -444.38M | 27.67% |
Cash from operations | 385.35M | 169.30% |
Cash from investing | -861.85M | 5.01% |
Cash from financing | 1.17B | -12.21% |
Net change in cash | 706.71M | 520.82% |
Free cash flow | -427.74M | 45.84% |
About
CEO
Founded
Apr 28, 2011
Website
Employees
4,872